PAXLOVID
Date
March 2022
Description
Paxlovid (also known as ritonavir-boosted nirmatrelvir) are oral antiviral pills used for the treatment of mild to moderate COVID-19 disease. This box was prescribed under a US Food and Drug Administration (FDA) emergency use authorization (EUA) in March
Source
US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Pfizer BioNTech
Citation
“ PAXLOVID,” The Global Health Chronicles, accessed June 1, 2023, https://globalhealthchronicles.org/items/show/8564.